Fairfax employs a clever M&A strategy called the "cannibal buy-up." When an asset is too large to acquire outright, they partner with another firm. Later, when financially stronger, they use their capital to buy out the partner's stake, allowing them to gain 100% control of a valuable asset over time.

While a soft market slows premium growth, it also reduces the need for capital to back new business. This frees up significant cash flow for Fairfax to execute accretive buybacks and other capital returns, especially when the stock trades at a discount to its intrinsic value.

The company's Total Return Swaps (TRS) are not just a speculative bet but a strategic tool. They function as a deferred buyback, allowing Fairfax to lock in a price while using the capital elsewhere until they formally close the swap and take delivery of the shares.

In a masterclass of capital allocation, Fairfax sold a 10% stake in its subsidiary, Odyssey, at a premium valuation (1.7x book). It then used the proceeds to repurchase its own parent company shares, which were trading at a discount (0.9x book), executing a perfect arbitrage.

Companies termed "share cannibals" aggressively repurchase their own shares, especially when undervalued. This capital allocation strategy is often superior to dividends because it transfers value from sellers to long-term shareholders and acts as a high-return, low-risk investment in the company's own business.

Fairfax follows a clear capital allocation framework. They prioritize open market buybacks when the stock is below 1.5 times price-to-book. Above that multiple, they shift capital towards closing out their Total Return Swaps, providing a predictable approach for investors.

After enduring a brutal multi-year short-seller campaign, Fairfax concluded that a fortress balance sheet is the ultimate defense. They now hold billions in cash and untapped credit lines, not just for operational safety, but specifically to make the company an unattractive target for future hedge fund attacks.

Fairfax executed a brilliant capital allocation move by selling a 10% stake in its subsidiary, Odyssey, to pension funds for 1.7 times its book value. They then used the billion-dollar proceeds to buy back their own undervalued parent company stock, which was trading at a discount of 0.9x book value.

Fairfax's multi-billion dollar gain during the 2008 crisis was not a speculative macro bet but a defensive one. They bought credit default swaps (CDS) as insurance against their own reinsurers, whom they identified as being dangerously exposed to mortgage-backed securities, protecting themselves from counterparty failure.